Literature DB >> 11922395

Androgen-dependent regulation of human MUC1 mucin expression.

Stephen Mitchell1, Paul Abel, Sanjeev Madaan, James Jeffs, Khurram Chaudhary, Gordon Stamp, El-Nasir Lalani.   

Abstract

MUC1 mucin is transcriptionally regulated by estrogen, progesterone, and glucocorticoids. Our objective was to determine whether androgen receptor (AR) activation regulates expression of MUC1. The following breast and prostatic cell lines were phenotyped and grouped according to AR and MUC1 protein expression: 1) AR+MUC1 + [DAR17+19 (AR transfectants of DU-145), ZR-75-1, MDA-MB-453, and T47D]; 2) AR-MUC1 + [DZeo1 (AR-vector control), DU-145, BT20, MDA-MB-231, and MCF7]; 3) AR+MUC1 - (LNCaP and LNCaP-r). Cell proliferation was determined using the MTT assay in the presence of synthetic androgen R1881, 0.1 microM to 1 microM. Cell surface MUC1 expression was determined by flow cytometry in the presence or absence of oestradiol, medroxy progesterone acetate or R1881, with and without 4 hydroxy-flutamide (4-OH), a nonsteroidal AR antagonist. The functional significance of MUC1 expression was investigated with a cell-cell aggregation assay. Only AR+MUC1 + cell lines showed a significant increase in MUC1 expression with AR activation (P (range) =.01 to .0001), reversed in the presence of 4-OHF. Cell proliferation was unaffected. Increased expression of MUC1 was associated with a significant (P (range) = .002 to .001) reduction in cell-cell adhesion. To our knowledge, this is the first description of androgen-dependent regulation of MUC1 mucin. This is also functionally associated with decreased cell-cell adhesion, a recognised feature of progressive malignancy. These findings have important implications for physiological and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922395      PMCID: PMC1503313          DOI: 10.1038/sj.neo.7900194

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  47 in total

Review 1.  MUC1: the polymorphic appearance of a human mucin.

Authors:  F G Hanisch; S Müller
Journal:  Glycobiology       Date:  2000-05       Impact factor: 4.313

2.  Human MUC1 mucin: a potent glandular morphogen.

Authors:  M J Hudson; G W Stamp; K S Chaudhary; R Hewitt; A P Stubbs; P D Abel; E N Lalani
Journal:  J Pathol       Date:  2001-07       Impact factor: 7.996

3.  MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence.

Authors:  A Ohgami; T Tsuda; T Osaki; T Mitsudomi; Y Morimoto; T Higashi; K Yasumoto
Journal:  Ann Thorac Surg       Date:  1999-03       Impact factor: 4.330

4.  The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein.

Authors:  A Baruch; M Hartmann; M Yoeli; Y Adereth; S Greenstein; Y Stadler; Y Skornik; J Zaretsky; N I Smorodinsky; I Keydar; D H Wreschner
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

5.  Phenotypic and genotypic characterization of commonly used human prostatic cell lines.

Authors:  S Mitchell; P Abel; M Ware; G Stamp; E Lalani
Journal:  BJU Int       Date:  2000-05       Impact factor: 5.588

6.  Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function.

Authors:  M A Okon; S M Laird; E M Tuckerman; T C Li
Journal:  Fertil Steril       Date:  1998-04       Impact factor: 7.329

7.  Expression of epidermal growth factor and androgen receptors in ovarian cancer.

Authors:  J V Ilekis; J P Connor; G S Prins; K Ferrer; C Niederberger; B Scoccia
Journal:  Gynecol Oncol       Date:  1997-08       Impact factor: 5.482

8.  Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma.

Authors:  K Nakagawa; J Akagi; E Takai; Y Tamori; T Okino; H Kako; H Egami; M Ogawa
Journal:  Int J Oncol       Date:  1999-03       Impact factor: 5.650

9.  p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system.

Authors:  M Hamaguchi; N Matsuyoshi; Y Ohnishi; B Gotoh; M Takeichi; Y Nagai
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

10.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

Authors:  J Wesseling; S W van der Valk; H L Vos; A Sonnenberg; J Hilkens
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  17 in total

1.  Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

Authors:  Robin R Hodges; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2013-08-14       Impact factor: 3.467

2.  Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis.

Authors:  Taylor E Escher; Asona J Lui; Eric S Geanes; Katherine R Walter; Ossama Tawfik; Christy R Hagan; Joan Lewis-Wambi
Journal:  Mol Cancer Res       Date:  2019-01-17       Impact factor: 5.852

Review 3.  [Lacrimal gland-associated mucins. Age related production and their role in the pathophysiology of dry eye].

Authors:  G Schäfer; W Hoffmann; M Berry; F Paulsen
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

4.  Tear film impairment and meibomian gland loss in patients with polycystic ovary syndrome.

Authors:  Yakup Acet; Sevcan Sarikaya
Journal:  Int Ophthalmol       Date:  2022-09-02       Impact factor: 2.029

Review 5.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

Review 6.  Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalk.

Authors:  Soha Salama El Sheikh; Jan Domin; Paul Abel; Gordon Stamp; El-Nasir Lalani
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

7.  Androgen regulation of gene expression in human meibomian gland and conjunctival epithelial cells.

Authors:  Payal Khandelwal; Shaohui Liu; David A Sullivan
Journal:  Mol Vis       Date:  2012-04-27       Impact factor: 2.367

8.  Conjunctival mucin deficiency in complete androgen insensitivity syndrome (CAIS).

Authors:  Flavio Mantelli; Costanzo Moretti; Alessandra Micera; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.535

9.  Prostatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis a.

Authors:  Vishwanath B Chachadi; Mohamed F Ali; Pi-Wan Cheng
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

10.  MUC1 as a Putative Prognostic Marker for Prostate Cancer.

Authors:  Rona J Strawbridge; Monica Nistér; Kerstin Brismar; Henrik Grönberg; Chunde Li
Journal:  Biomark Insights       Date:  2008-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.